calmidazolium has been researched along with hydroxocobalamin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Büyükafşar, K; Kıroğlu, OE; Özü, ÖY; Seçilmiş, MA; Şingirik, E | 1 |
| Bayel, İ; Emre, M; Kıroğlu, OE; Kumcu, EK; Özü, ÖY; Seçilmiş, MA | 1 |
2 other study(ies) available for calmidazolium and hydroxocobalamin
| Article | Year |
|---|---|
The production of vasoconstriction-induced residual NO modulates perfusion pressure in rat mesenteric vascular bed.
Topics: Animals; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Hydroquinones; Hydroxocobalamin; Imidazoles; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Rats; Rats, Wistar; Staurosporine; Vitamin B Complex | 2014 |
Residual NO modulates contractile responses and membrane potential in isolated rat mesenteric arteries.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Benzoates; Free Radical Scavengers; Hydroxocobalamin; Imidazoles; Male; Membrane Potentials; Mesenteric Arteries; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Phenylephrine; Protein Kinase Inhibitors; Rats, Wistar | 2017 |